Evidence map›Paper›PMID 40867011›Full record

ArticleNutrition & metabolism2025

Sugar-sweetened beverage consumption and risk of premature coronary artery disease in a multi-ethnic Iranian case-control study.

Noushin Mohammadifard, Negar Ostadsharif, Ghazaleh Bahrami, Motahare Bateni, Ehsan Zarepur, Fatemeh Nouri, Fereidoon Nouhi, Nahid Azdaki, Nahid Salehi, Masoud Lotfizadeh and 8 more

Abstract read
In one paragraph

Article in Nutrition & metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Noushin MohammadifardInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Negar OstadsharifStudent Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Ghazaleh BahramiStudent Research Committee, Isfahan University of Medical sciences, Isfahan, Iran.
Motahare BateniInterventional Cardiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Ehsan ZarepurCardiology resident and Manager of I-PAD project, Isfahan University of Medical Sciences, Isfahan, Iran.
Fatemeh NouriIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Fereidoon NouhiRajaie Cardiovascular Medical and Research Center, Iran University of Medical Sciences, Tehran, Iran.
Nahid AzdakiCardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.
Nahid SalehiCardiovascular Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Masoud LotfizadehDepartment of Community Health, Shahrekord University of Medical Sciences, Shahrekord, Iran.
Samad GhaffariCardiovascular Research Center, Tabriz University of Medical sciences, Tabriz, Iran.
Arsalan SalariCardiovascular Diseases Research Center, Department of Cardiology, School of Medicine, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.
Mostafa DehghaniDepartment of Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran.
Mostafa CheraghiDepartment of Cardiovascular Research Center, Shahid Rahimi Hospital, Lorestan University of Medical Sciences, Khorramabad, Iran.
Ahmadreza AssarehAtherosclerosis Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Hassan AlikhasiHeart Failure Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Fahimeh HaghighatdoostIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran. f_haghighatdoost@yahoo.com.
Nizal SarrafzadeganIsfahan Cardiovascular Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association of sugar sweetened beverages (SSBs) and coronary artery disease (CAD) has not been well-established in Asians, where SSBs are the leading ultra-processed food product.

objectiveWe aim to examine the association between SSBs and premature CAD (PCAD) in Iranian adults.

designCase-control.

participantsA multi-centric study of Iranians including 2006 PCAD and 1131 healthy individuals as control group.

main outcome measuresDietary intakes were assessed using a validated food frequency questionnaire (FFQ). SSBs consist of artificial juice and sugar -sweetened drinks. The PCAD was determined based on the results of angiography and the occlusion percent of vessels. STATISTICAL ANALYSIS: The odds of PCAD across the quartiles of SSBs were assessed by binary logistic regression.

resultsThe mean (SD) age of participants and SSB consumption was 51.5 years and 46.9 g/d, respectively. In the fully-adjusted model, compared with participants in the first quartile, those in the fourth quartile had higher risk of PCAD (OR = 1.50, 95% CI: 1.12, 2.00; P trend = 0.044). Consistently, SSB consumption was directly associated with the severity of PCAD. The higher SSB consumption, the greater risk for the severe PCAD (OR Q4 vs. Q1 = 1.34, 95% CI: 1.06, 1.68; P < 0.001).

conclusionThis study demonstrated that higher consumption of SSB might be associated with higher risk of PCAD. However, more prospective cohort studies are necessary to confirm this association.

Indexed as

Cardiovascular diseaseCoronary artery disease, IranSoft drinkSugar-Sweetened beverages

Identifiers

PMID40867011
PMCPMC12392546

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.